Keywords: boehringer, ingelheim, nascacell, enter, alliance, germany, say

Boehringer Ingelheim and NascaCell enter alliance

Article | 21 February 2005

Print This

Germany's Boehringer Ingelheim and NascaCell say they have signed a deal on aptamer-based target validation and drug discovery. Under the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in